Enphase Energy Inc vs 22nd Century Group Inc — how do they compare? Enphase Energy Inc trades at $42.6 (market cap $5.81B), while 22nd Century Group Inc trades at $4.27 (market cap $1.52M). The key difference: Enphase Energy Inc is far larger — about 3822.4× 22nd Century Group Inc's market cap. Which is the better fit depends on your goals.
| ENPH | XXII | |
|---|---|---|
Market Cap | $5.81B | $1.52M |
Sector | Technology | Technology |
52-Week High | $72.33 | $1.47K |
52-Week Low | $26.12 | $3.90 |
Enterprise Value | $5.46B | -$6.71M |
Signals from Pluang's Aura AI — not financial advice
Enphase Energy (ENPH) trades at $44.985, up 4.47% with a neutral technical signal despite bullish moving averages. The company has beaten earnings expectations for three consecutive quarters, though revenue declined from $2.3B in 2023 to $1.47B in 2025. Analyst sentiment is mixed with 40% buy ratings but a consensus price target of $42.79 below current levels. Recent news highlights product expansions in Europe and Australia alongside ongoing legal scrutiny.
ENPH faces near-term headwinds with declining revenue and compressed margins, but maintains strong profitability metrics and consistent earnings beats. Investment appeal hinges on international growth execution and potential regulatory tailwinds, balanced against competitive pressures and stock volatility. The current valuation at 43.61 P/E requires robust growth reinstatement to justify upside.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
Read more on ENPH →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →